The focus of research in the Department of Prof. Dr. Ralf H. Adams is to elucidate which molecular signals regulate the development of blood vessels in the body.

Prof. Dr. Rui Benedito's new department is developing novel genetic technologies to understand how genetic mutations alter the function of individual cells and cause disorders such as cardiovascular disease and cancer. The aim is to precisely analyse disease-relevant genetic changes and make their biological consequences traceable in living organisms.

Scientists in the Department of Prof. Sara Wickström, MD, PhD are investigating which processes of stem cell regulation are tissue-specific and which are more general and thus apply to most, if not all, mammalian cell types. In addition, one goal is to apply the findings to the engineering of organs such as skin in vitro.

Prof. Dr. Dietmar Vestweber was granted emeritus status on January 1, 2025 and continues his research in the Vascular Cell Biology Emeritus Group until December 2026.

After receiving emeritus status in November 2021, Prof. Dr. Hans Schöler continued his research on the White Paper Emeritus Group until October 2023. He is still affiliated with the Institute as Director Emeritus.